Kurv Yield Prem Strategy Tesla ETF (TSLP)
| Assets | $21.89M |
| Expense Ratio | 1.00% |
| PE Ratio | 120.49 |
| Shares Out | 1.13M |
| Dividend (ttm) | $8.96 |
| Dividend Yield | 46.01% |
| Ex-Dividend Date | Jul 2, 2025 |
| Payout Frequency | Monthly |
| Payout Ratio | 5,461.92% |
| Volume | 21,754 |
| Open | 19.90 |
| Previous Close | 19.77 |
| Day's Range | 19.49 - 19.90 |
| 52-Week Low | 15.36 |
| 52-Week High | 34.29 |
| Beta | n/a |
| Holdings | 13 |
| Inception Date | Oct 27, 2023 |
About TSLP
Fund Home PageThe Kurv Yield Prem Strategy Tesla ETF (TSLP) is an exchange-traded fund that mostly invests in consumer discretionary equity. The fund seeks to provide current income and capped gains on the Tesla stock (TSLA) through a synthetic covered call strategy, collateralized by cash and short-term fixed-income instruments. The actively managed fund uses both standardized exchange-traded and FLEX options. TSLP was launched on Oct 27, 2023 and is issued by Kurv.
Top 10 Holdings
128.84% of assets| Name | Symbol | Weight |
|---|---|---|
| United States Treasury Bills 0% | B.0 03.19.26 | 43.97% |
| United States Treasury Bills 0% | B.0 09.18.25 | 29.44% |
| United States Treasury Bills 0% | B.0 12.26.25 | 29.10% |
| Tsla 09/19/2025 330 C | n/a | 13.64% |
| Fidelity Government Portfolio | FIGXX | 8.10% |
| TSLA US 07/18/25 C355 | n/a | 2.64% |
| TSLA US 08/15/25 P250 | n/a | 0.56% |
| Cash Offset | n/a | 0.50% |
| TSLA US 07/18/25 C375 | n/a | 0.49% |
| DEPOSITS WITH BROKER FOR SHORT POSITIONS | n/a | 0.39% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jul 2, 2025 | $0.450 | Jul 3, 2025 |
| Jun 4, 2025 | $0.500 | Jun 5, 2025 |
| May 7, 2025 | $0.550 | May 8, 2025 |
| Apr 2, 2025 | $0.550 | Apr 3, 2025 |
| Mar 5, 2025 | $0.700 | Mar 6, 2025 |
| Feb 5, 2025 | $1.000 | Feb 6, 2025 |
Performance
TSLP had a total return of 16.86% in the past year, including dividends. Since the fund's inception, the average annual return has been 18.88%.
News
Kurv Investment Management Completes Reorganization of Yield Premium Suite to Proprietary Trust
SAN FRANCISCO--(BUSINESS WIRE)--Kurv Investment Management, an ETF provider of tax-efficient, institutional-grade investment strategies, announces the successful reorganization of its Yield Premium Su...
AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca will showcase new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic Soci...